- Home
- DTCK vs LPCN Comparison
DTCK vs LPCN Comparison
Compare DTCK & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- LPCN
- Stock Information
- Founded
- DTCK 1999
- LPCN 1997
- Country
- DTCK Singapore
- LPCN United States
- Employees
- DTCK N/A
- LPCN N/A
- Industry
- DTCK Farming/Seeds/Milling
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- LPCN Health Care
- Exchange
- DTCK Nasdaq
- LPCN Nasdaq
- Market Cap
- DTCK 19.3M
- LPCN 16.1M
- IPO Year
- DTCK 2023
- LPCN N/A
- Fundamental
- Price
- DTCK $0.86
- LPCN $3.15
- Analyst Decision
- DTCK
- LPCN Strong Buy
- Analyst Count
- DTCK 0
- LPCN 2
- Target Price
- DTCK N/A
- LPCN $9.00
- AVG Volume (30 Days)
- DTCK 372.6K
- LPCN 37.3K
- Earning Date
- DTCK 04-30-2025
- LPCN 08-11-2025
- Dividend Yield
- DTCK N/A
- LPCN N/A
- EPS Growth
- DTCK N/A
- LPCN N/A
- EPS
- DTCK N/A
- LPCN N/A
- Revenue
- DTCK $132,369,000.00
- LPCN $3,674,834.00
- Revenue This Year
- DTCK N/A
- LPCN N/A
- Revenue Next Year
- DTCK N/A
- LPCN N/A
- P/E Ratio
- DTCK N/A
- LPCN N/A
- Revenue Growth
- DTCK N/A
- LPCN N/A
- 52 Week Low
- DTCK $0.40
- LPCN $2.68
- 52 Week High
- DTCK $1.50
- LPCN $6.17
- Technical
- Relative Strength Index (RSI)
- DTCK 48.45
- LPCN 45.50
- Support Level
- DTCK $0.75
- LPCN $3.24
- Resistance Level
- DTCK $0.95
- LPCN $3.45
- Average True Range (ATR)
- DTCK 0.11
- LPCN 0.20
- MACD
- DTCK -0.02
- LPCN 0.00
- Stochastic Oscillator
- DTCK 33.14
- LPCN 25.00
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.